Publications by authors named "Z Adamova"

Background: Histiocytoses are rare disorders characterized by the accumulation of macrophages, dendritic cells, or monocyte-derived cells in various tissues and organs of children and adults, with a wide range of clinical manifestations, presentations, and histology. The histiocytoses are classified according to the WHO Classification, the last version of which was published in 2022, or according to the Histiocyte Society Classification, with the last version published in 2016.

Purpose: This text provides an overview of histiocytoses as described in the WHO Classification 2022.

View Article and Find Full Text PDF
Article Synopsis
  • A 54-year-old man with obesity, hypertension, and a long history of abdominal pain underwent various medical tests over 12 years, revealing multiple ulcers but no clear diagnosis initially.
  • In 2022, he was diagnosed with gastrinoma, a type of neuroendocrine tumor, after advanced imaging techniques identified a lesion not visible on CT scans.
  • The report emphasizes the need to consider neuroendocrine tumors in similar cases and supports using 68Ga-DOTATOC PET/CT scans over older imaging methods for accurate diagnosis.
View Article and Find Full Text PDF

Introduction: Major surgery poses a significant stress to the patient. The nutritional status is one of crucial factors that have a substantial impact on the final outcome of the surgery. Preoperatively established malnutrition or an increased nutritional risk in this group of patients requires a maximum effort to minimize this negative impact as soon as the operation is scheduled.

View Article and Find Full Text PDF

Background: Idiopathic multicentric Castleman disease (iMCD) is characterized by constitutional symptoms, enlarged lymph nodes and laboratory test abnormalities, which are primarily related to the overproduction of interleukin-6 (IL-6). This form (iMCD) was treated earlier with cytostatics used for lymphoma, later with bio-logic therapy as rituximab, immunodulatory drugs and proteasome inhibitors, and in the last years with an anti-IL-6 antibody, siltuximab. Siltuximab is a human-mouse chimeric immunoglobulin G1k monoclonal antibody against human IL-6 approved in the European Union for the treatment of iMCD.

View Article and Find Full Text PDF

SAPHO is an acronym derived from capital letters of Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO). SAPHO syndrome is an umbrella term covering a constellation of bone lesions and skin manifestations. A 40-year-old male complained about his jaw and back pain, swelling of multiple joints and weight loss accompanied by physical deterioration and acne type skin lesions.

View Article and Find Full Text PDF